The i-limb has been designed with the aim of restoring independence and self esteem to individuals with upper limb loss. Ian Stevens will describe how multi-articulating hands are advancing in their dexterity and utility, allowing wearers to perform activities of daily living once again.
Speaker Biography (Ian Stevens)
Ian joined Touch Bionics as CEO in 2011 from surgical medical device company Mpathy Medical where he had been CEO since 2007. Between 1998 and 2007 he was employed by Optos plc, a medical technology company specializing in the imaging of the retina, firstly in the roles of CFO in Dunfermline, UK, and then from 2003 as General Manager, North America in Boston, USA. Ian is a chartered accountant and graduate of Edinburgh University.
Company Profile (Touch Bionics)
Touch Bionics is a provider of world-leading prosthetic technologies designed to achieve positive outcomes for people with upper limb deficiencies. Touch Bionics was the first company to develop an electrically powered prosthetic hand with five independently powered fingers and the company continues to be a pioneer in upper limb prosthetic solutions. The company's products include electronic prosthetic hand and prosthetic finger solutions, as well as passive silicone prostheses that closely match the natural appearance of the wearer.
A spin-out from the UK's National Health Service, Touch Bionics was founded by inventor David Gow and is funded and supported by Archangel Investors Limited and Scottish Enterprise.